Fast-track diagnosis for Giant Cell Arteritis
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
Groupe Hospitalier de la Rochelle Ré Aunis · NCT06742671
This study is testing a new way to quickly diagnose Giant Cell Arteritis using ultrasound to see if it can help patients get the right treatment faster and avoid serious complications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Groupe Hospitalier de la Rochelle Ré Aunis (other) |
| Locations | 1 site (La Rochelle) |
| Trial ID | NCT06742671 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on improving the diagnosis of Giant Cell Arteritis (GCA), a serious condition that can lead to vision loss or stroke if not identified quickly. It leverages advanced ultrasound techniques to detect inflammation in the temporal arteries, potentially eliminating the need for invasive biopsies in patients with high clinical suspicion of GCA. The study aims to validate the effectiveness of a fast-track diagnostic pathway based on ultrasound findings. By streamlining the diagnostic process, the study seeks to enhance patient outcomes through timely intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals over 50 years old who are suspected of having Giant Cell Arteritis.
Not a fit: Patients who do not exhibit clinical signs of Giant Cell Arteritis or refuse the use of their data may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the time to diagnosis and treatment for patients with Giant Cell Arteritis.
How similar studies have performed: Previous studies have shown success in using ultrasound for diagnosing Giant Cell Arteritis, indicating that this approach is promising and not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient suspected of GCA Exclusion Criteria: * Opposition to the use of their data
Where this trial is running
La Rochelle
- Groupe Hospitalier de la Rochelle Ré Aunis — La Rochelle, France (RECRUITING)
Study contacts
- Study coordinator: Caroline Allix-Béguec, Ph.D.
- Email: caroline.allix-beguec@ght-atlantique17.fr
- Phone: +33516494246
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Giant Cell Arteritis, diagnostic test, ultrasonography, Doppler, color, temporal arteries, biopsy, fast track clinic